首页|Department of Nuclear Medicine Reports Findings in Artificial Intelligence (Diagnostic performance of artificial intelligence-assisted PET imaging for Parkinson's disease: a systematic review and metaanalysis)
Department of Nuclear Medicine Reports Findings in Artificial Intelligence (Diagnostic performance of artificial intelligence-assisted PET imaging for Parkinson's disease: a systematic review and metaanalysis)
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
New research on Artificial Intelligence is the subject of a report. According to news reporting originating from Zhejiang, People’s Republic of China, by NewsRx correspondents, research stated, “Artificial intelligence (AI)-assisted PET imaging is emerging as a promising tool for the diagnosis of Parkinson’s disease (PD). We aim to systematically review the diagnostic accuracy of AI-assisted PET in detecting PD.” Our news editors obtained a quote from the research from the Department of Nuclear Medicine, “The Ovid MEDLINE, Ovid Embase, Web of Science, and IEEE Xplore databases were systematically searched for related studies that developed an AI algorithm in PET imaging for diagnostic performance from PD and were published by August 17, 2023. Binary diagnostic accuracy data were extracted for meta-analysis to derive outcomes of interest: area under the curve (AUC). 23 eligible studies provided sufficient data to construct contingency tables that allowed the calculation of diagnostic accuracy. Specifically, 11 studies were identified that distinguished PD from normal control, with a pooled AUC of 0.96 (95% CI: 0.94-0.97) for presynaptic dopamine (DA) and 0.90 (95% CI: 0.87-0.93) for glucose metabolism (F-FDG). 13 studies were identified that distinguished PD from the atypical parkinsonism (AP), with a pooled AUC of 0.93 (95% CI: 0.91 - 0.95) for presynaptic DA, 0.79 (95% CI: 0.75-0.82) for postsynaptic DA, and 0.97 (95% CI: 0.96-0.99) for F-FDG. Acceptable diagnostic performance of PD with AI algorithms-assisted PET imaging was highlighted across the subgroups.”
ZhejiangPeople’s Republic of ChinaAsiaArtificial IntelligenceBasal Ganglia Diseases and ConditionsBrain Diseases and ConditionsCentral Nervous System Diseases and ConditionsDiagnostics and ScreeningEmerging TechnologiesHealth and MedicineMachine LearningMovement DisordersNervous System Diseases and ConditionsNeurodegenerative Diseases and ConditionsParkinson’s DiseaseParkinsonian Disorders
NETL
NSTL
